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ABSTRACT 
Rationale, aims and objectives: Program evaluations often utilize various matching approaches to 
emulate the randomization process for group assignment in experimental studies. Typically, the 
matching strategy is implemented and then covariate balance is assessed before estimating 
treatment effects. This paper introduces a novel analytic framework utilizing a machine learning 
algorithm called optimal discriminant analysis (ODA) for assessing covariate balance and 
estimating treatment effects, once the matching strategy has been implemented. This framework 
holds several key advantages over the conventional approach: application to any variable metric 
and number of groups; insensitivity to skewed data or outliers; and use of accuracy measures 
applicable to all prognostic analyses. Moreover, ODA accepts analytic weights, thereby 
extending the methodology to any study design where weights are used for covariate adjustment 
or more precise (differential) outcome measurement. 
Method: One-to-one matching on the propensity score was used as the matching strategy. 
Covariate balance was assessed using standardized difference in means (conventional approach) 
and measures of classification accuracy (ODA). Treatment effects were estimated using ordinary 
least squares regression and ODA.  
Results: Using empirical data, ODA produced results highly consistent with those obtained via 
the conventional methodology for assessing covariate balance and estimating treatment effects.  
Conclusions: When ODA is combined with matching techniques within a treatment effects 
framework, the results are consistent with conventional approaches. However, given that it 
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provides additional dimensions and robustness to the analysis versus what can currently be 
achieved using conventional approaches, ODA offers an appealing alternative.   
This article is protected by copyright. All rights reserved.
INTRODUCTION 
In experimental studies with two arms (treatment and control), outcomes may be analyzed by 
simply regressing the outcome on a treatment group indicator variable in order to estimate 
treatment effects. This minimal design is sufficient to provide unbiased treatment effect 
estimates when subjects are randomized. However, when analyzing non-randomized 
observational data, investigators estimate treatment effects by applying causal-inferential 
methods to control for threats to validity [1]. When evaluating health management programs, 
selection bias is a particularly prominent threat to validity because individuals with high levels of 
health care utilization or costs are specifically targeted for enrollment. Given their high outlier 
status at baseline, these individuals’ outcomes are naturally likely to regress to the mean on their 
follow-up measurement, giving the false impression of a treatment effect [2,3]. 
 In observational studies, investigators typically choose from a wide variety of matching 
approaches in an attempt to emulate the randomization process for group assignment using 
observational data [4]. However, unlike most experimental studies in which study groups are 
inherently comparable on both observed and unobserved pre-intervention characteristics, 
matching studies can only endeavor to generate study groups that are comparable on observed 
characteristics and must assume that any unmeasured variables will not bias the results [5]. Thus, 
in evaluating a health management program using a matching approach, the investigator would 
ensure that study groups were comparable on pre-intervention levels of health care utilization 
and cost, but must assume, for example, that unmeasured motivation to change health behaviors 
will not confound the outcomes [6,7]. Accordingly, an essential condition for assuming the 
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validity of treatment effects in matching studies is that the study groups are comparable on their 
observed pre-intervention characteristics [8,9]. 
 Recently, Linden & Yarnold [10] introduced a novel machine-learning approach for 
assessing comparability between study groups in matching studies. This methodology employs 
an algorithm called optimal discriminant analysis (ODA) to determine if, and to what degree, 
study groups can be distinguished based on the distributions of the covariates [11,12]. Matching 
is considered successful if the ODA algorithm fails to identify characteristics that discriminate 
between the groups.  
 In this paper we extend this machine-learning approach to program evaluations that use 
matching as the basis for ensuring comparability between study groups. By framing the 
treatment-outcome relationship as a classification problem (i.e., how accurately does the 
outcome variable classify individuals as being in the treatment or control group) ODA offers 
several benefits over the conventional statistical methods typically employed in matching 
studies. These include the ability to handle an outcome variable measured using any metric (from 
categorical to continuous) and multiple treatment groups, insensitivity to skewed data or outliers, 
and the use of accuracy measures that can be widely applied to all classification analyses. ODA 
also offers the unique ability to ascertain if individuals are likely to be responding to the 
treatment as assigned (or self-selected) based on optimized (maximum-accuracy) cut-points on 
the outcome variable. Moreover, ODA accepts analytic weights, thereby allowing the evaluation 
of observational studies using any matching algorithm that produces weights for covariate 
adjustment [10]. Finally, ODA provides the capability to use cross-validation in assessing the 
This article is protected by copyright. All rights reserved.
generalizability of the model to other individuals outside of the original study sample, or to 
identify solutions that cross-generalize with maximum accuracy when applied across multiple 
samples [12]. 
 To illustrate the ODA-matching framework, and compare it to the conventional method, 
the paper is organized as follows. In the Methods section we provide a brief introduction to 
ODA, and describe the data source and analytic framework employed in the current study. The 
Results section reports and compares the results of the conventional approach and ODA-
matching framework. The Discussion section describes the specific advantages of ODA-
matching framework for assessing covariate balance and evaluating treatment effects compared 
with the conventional approach, and discusses how machine-learning can be applied more 
broadly within the causal inferential framework.  
METHODS 
A brief introduction to optimal discriminant analysis 
ODA is a machine learning algorithm that was introduced over 25 years ago to offer an 
alternative analytic approach to conventional statistical methods commonly used in research 
[13]. Its appeal lies in its simplicity, flexibility, and accuracy as compared to conventional 
methods [12,14,15]. 
 To briefly describe how an ODA model is obtained, assume we have a continuous 
outcome (attribute) and a binary treatment (class) variable. First, we order the outcome variable 
from low to high. Next, we find all the points along the continuum of the outcome in which the 
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next value belongs to an individual from the alternate class than that of the previous value (e.g. 
the next value belongs to a treated subject whereas the previous value belongs to a control). The 
cutpoint thus represents the mean value of the outcome at this point: cutpoint = (previous value + 
current value) / 2. Directionality defines how cutpoints are used to classify individual 
observations. The two directions are “less than” (controls have lower values on the outcome than 
treated subjects), and “greater than” (controls have higher values on the outcome than treated 
subjects). For an exploratory “two-tailed” hypothesis (controls and treated subjects have different 
values on the outcome), both directions are evaluated by the ODA algorithm. For a confirmatory 
“one-tailed” hypothesis (controls have lower values), only the appropriate direction (less than) is 
evaluated. For each cutpoint along the continuum of the outcome, ODA assesses how well the 
model—that is, the combination of cutpoint and direction—correctly predicts (in the current 
example) that controls have values of the outcome less than or equal to the cutpoint, and treated 
subjects have values of the outcome greater than the cutpoint [12,13]. 
 ODA relies on three measures of accuracy to identify the optimal (maximum-accuracy) 
model – that is, the exact combination of cutpoint and direction that produces the most accurate 
predictions possible for the sample. Sensitivity or true positive rate is the proportion of actual 
treated subjects that are correctly predicted by the ODA model -- that is, those who have a value 
on the outcome that lies above the cutpoint. Specificity or true negative rate is the proportion of 
actual control subjects that are correctly predicted by the ODA model – that is, those who have a 
value on the outcome that lies at or below the cutpoint [16]. The third measure of accuracy 
combines these two metrics and is called the effect strength for sensitivity or ESS [11,12]. ESS is 
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a chance-corrected (0 = the level of accuracy expected by chance) and a maximum-corrected 
(100 = perfect prediction) index of predictive accuracy. The formula for computing ESS for a 
binary (two-category) case classification result is: 
     ESS = [(Mean Percent Accuracy in Classification –50)]/ 50 x 100%   (1),  
where  
     Mean Percent Accuracy in Classification = (sensitivity + specificity)/2 x 100   (2).   
 The ODA algorithm iterates through each successive cutpoint and calculates ESS. The 
maximally-accurate model is that which has the cutpoint and direction with the highest 
associated value of ESS. Based on simulation research, ESS values <25% conventionally 
indicate a relatively weak, <50% indicate a moderate, 50-75% indicate a relatively strong, and 
>75% indicate a strong effect [11,12]. 
 ODA also computes P-values to assess the statistical reliability (or “significance”) of the 
maximally-accurate ODA model. P-values are estimated using Monte Carlo permutation 
experiments. For example, in models with a binary treatment, this involves repeatedly shuffling 
subjects’ treatment assignment at random, holding their outcome value fixed at its true value. In 
each permuted dataset the ESS is recorded, and the permutation P-value represents the 
proportion of all permuted datasets in which the ESS is higher than the ESS of the maximally-
accurate ODA model [11,12,13]. 
 Finally, ODA can be implemented using cross-validation to assess the generalizability of 
the model, using methods such as k-fold cross-validation, bootstrapping, and leave-one-out 
jackknife cross-validation [18,17,12]. This typically entails first estimating a model using a 
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training sample and calculating the accuracy measures, followed by applying the same model to 
one or more hold-out (test) samples and then recalculating the accuracy measures. If the 
accuracy measures remain consistent with those of the original model using the entire sample, 
then the model is considered generalizable. This may be important, for example, if the goal of 
the analysis is to assist health researchers identify new candidates for participation in an ongoing 
intervention, or initiate the intervention in other settings. Cross-validation is less important if the 
goal is only to estimate treatment effects of the existing intervention [10,19,20]. 
Data 
Our empirical example uses data from a prior evaluation of a primary care-based medical home 
pilot program that invited patients to enroll if they had a chronic illness or were predicted to have 
high costs in the following year. The goal of the program was to lower healthcare costs for 
program participants by providing intensified primary care (see [21] for a more comprehensive 
description). The retrospectively collected data consist of observations for 374 program 
participants and 1,628 non-participants. Eleven pre-intervention characteristics were available; 
these included demographic variables (age and gender), health services utilization in year prior to 
enrollment (primary care visits, other outpatient visits, laboratory tests, radiology tests, 
prescriptions filled, hospitalizations, emergency department visits, and home-health visits) and 
total medical costs (the amount paid for all those health services utilized in the prior year). 
Analytic approach 
Matching studies involve a sequential process in which the chosen matching strategy is 
implemented, covariate balance is assessed (i.e., comparability between study groups on pre-
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intervention characteristics), and then treatment effects are estimated [4,8,9]. This approach 
serves to emulate an experimental study by decoupling the design phase (matching on pre-
intervention characteristics without consideration of the outcome as would be the case in a 
prospective study) from the analysis [22]. 
 While any matching algorithm could be employed within our proposed machine-learning 
framework, for the purpose of this empirical example, a one-to-one, propensity score based 
matching approach was used, as implemented in Linden [21]. The propensity score is defined as 
the probability of assignment to the treatment group given the observed characteristics [23]. To 
be consistent with prior research we estimated the propensity score via the conventional 
approach of using logistic regression to predict program participation status using the eleven pre-
intervention covariates described above, all entered as main effects. It has been demonstrated 
that in large samples, when treatment and control groups have similar distributions of the 
propensity score, they generally have similar distributions of the underlying covariates used to 
create the propensity score. This means that observed baseline covariates can be considered 
independent of treatment assignment (as if they were randomized), and therefore will not bias the 
treatment effects [23]. To achieve this similar distribution of the propensity score, an optimal 
matching algorithm [24] was used to match pairs (one participant to one non-participating 
control) on the estimated propensity score, resulting in 276 matched pairs [21]. 
 Next, the effectiveness of the matching approach in reducing bias was examined by 
assessing covariate balance, comparing the conventional method to ODA: the conventional 
method compares the standardized difference in means [25], and ODA utilizes the 
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aforementioned measures of accuracy – sensitivity, specificity, and ESS [11,12,16]. The 
expectation is that a well-matched cohort will have standardized differences close to zero, and 
poor (i.e., low) measures of accuracy [10]. 
The outcome analysis was performed by regressing health care costs in the program year 
on the treatment variable using ordinary least squares regression (OLS) with robust standard 
errors [26,27], and an exploratory ODA model was obtained in which health care costs was used 
as the attribute and treatment as the class variable, without specifying a priori directionality (i.e., 
hypothesizing a positive or negative difference over time). Exact P values were estimated using 
25,000 Monte Carlo experiments [12]. 
Both analyses were performed on the unmatched population (naïve estimate) and on the 
matched sample (adjusted), in order to assess the degree to which matching reduced confounding 
and altered the treatment effect estimates.   
Stata 14.1 (StataCorp., College Station, TX, USA) was used to conduct all conventional 
statistical analyses (i.e. covariate balance and outcome analyses using OLS regression), and 
ODA analyses were performed using UniODA Software [11]. 
RESULTS 
Tables of covariate balance, before and after matching, are replicated from Linden [21] 
and Linden & Yarnold [10] and are presented in Tables 1-4. Both conventional and ODA 
methods found that matching generated comparable study groups based on the observed pre-
intervention characteristics. In the former, standardized differences close to zero and P-values > 
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0.05 (Table 2). In the latter, we found consistently weak ESS values with permuted P values > 
0.05 except for prescriptions filled (P < 0.027, Table 4). 
 Table 5 presents program year costs (outcome) for participants and non-participants, both 
unadjusted and after one-to-one matching, using conventional OLS regression. As shown, the 
naïve treatment effect estimate (not controlling for confounding) is $4,038 (95% CI: 2,922, 
5,154). In other words, while the treatment group is estimated to have statistically significantly 
higher (P < 0.0001) health care costs in the program year than the unmatched pool of non-
participants, the regression model fails to explain the vast majority of the variance in health care 
costs between the two groups (97.59% remains unexplained). However, after controlling for 
confounding via matching, the subset of treated subjects was estimated to have program year 
costs that was, on average, $1,501 lower than that of the control group – but that was statistically 
indistinguishable from the control group (P < 0.193; 95% CI: -3,762, 760). 
 Table 6 presents program year costs (outcome) for participants and non-participants, both 
unadjusted and after one-to-one matching, using ODA as the analytic tool. Summary values 
represent the cutoff point on the outcome, sensitivity is presented for participants, and specificity 
is presented for non-participants. The ESS is reported as a measure of “clinical” importance (for 
which higher percentage values represent better classification accuracy and ability to 
discriminate between groups), and permuted P-values are reported as a measure of statistical 
significance. As shown for the naïve estimate, the ODA model predicted that an individual was a 
participant in the study if their program year cost was lower than $2,773 and a non-participant if 
their program year cost was equal to or greater than $2,773. The ODA model correctly classified 
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85.03% of participants and 71.74% of non-participants according to their cost. Classification 
performance was relatively strong (ESS = 56.77%) and statistically significant (P < 0.0001). 
However, after controlling for confounding via matching, ODA reported only a relatively weak 
clinical effect (ESS = 10.87%) that was not statistically significant (P < 0.076).  
 Taken as a whole, the statistical analysis findings obtained using ODA (Table 6) are 
almost perfectly consistent with findings obtained using OLS regression (Table 5), whether not-
adjusting or adjusting for confounding and selection bias. For both frameworks, the naïve 
estimate indicates that the treatment group had statistically higher costs in the intervention period 
compared to the non-treated group (P < 0.0001, for both regression and ODA), while the 
adjusted estimate indicates that the treatment group had non-statistically lower costs in the 
intervention period compared to the non-treated group (P = 0.193 and P = 0.076, for regression 
and ODA, respectively). 
DISCUSSION 
Our results demonstrate that ODA can be combined with a matching approach as a strategy that 
is equally effective as conventional methods to improve causal inference in program evaluations. 
And while we used one-to-one matching in this particular example, the ODA algorithm can be 
extended to any matching design where weights are used for covariate adjustment (see for 
example [28,29,30,31,32,33]). It is important to note that conventional and ODA analyses may 
not always produce consistent results. Prior studies comparing the two methods have obtained 
strongly divergent findings in a wide variety of real-world data and research designs [11,12]. A 
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good rule of thumb would be to perform the program evaluation using both conventional and 
ODA frameworks, and then compare the resulting treatment effect estimates. If both methods 
provide consistent results, then the investigator should be confident that, at the very least, the 
estimate is insensitive to distributional assumptions required for the OLS model, and also more 
likely to be a reflection of the true treatment effect estimate. However, if the approaches result in 
conflicting treatment effect estimates, the investigator should consider the ODA derived estimate 
to be more robust, given that ODA uses permutation P values that require no distributional 
assumptions and are always valid. 
 ODA is an appealing alternative framework in program evaluation because it holds 
several advantages over conventional methods for assessing covariate balance, outcomes, or 
both, in observational studies. First, the ODA algorithm, with its associated measure of 
classification performance (ESS) and non-parametric permutation tests, can be universally 
applied to any variable type and number of study groups (e.g., various treatment conditions or 
various doses of a particular treatment), and is not affected by skewed data or outliers – a 
concern that may arise in the context of meeting assumptions underlying the validity of the 
estimated P-value using conventional statistics alone (for example, as is evident in the current 
data by the large standard errors for the treatment effect estimates presented in Table 5). 
 Second, within the proposed treatment effects framework, ODA can also help explain (a) 
how individuals self-select in observational studies (by identifying group membership based on 
the cut-point on any given covariate) [10], and (b) how individuals are likely to respond to the 
intervention (by identifying where individuals are relative to the cutpoint on the outcome) [34]. 
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Such detail can allow administrators to fine-tune the enrollment criteria to target those 
individuals who will most likely benefit from the program [20], while concomitantly allowing 
administrators to improve their estimates of which individuals actually benefit from the program. 
 Finally, ODA can be implemented using cross-validation to assess the generalizability of 
the model to new candidates for participation in the existing intervention, or to initiate the 
intervention in other settings. Cross-validation is less important if the goal is only to estimate 
treatment effects of the intervention [19,20]. 
 While this paper specifically focused on creating a framework in which machine learning 
and matching approaches can be combined to improve causal inference in program evaluation, 
there are several additional ways in which machine learning techniques can be applied in causal 
inferential work. For example, Linden and Yarnold [20] use classification tree analysis (CTA) to 
characterize the nature of individuals who choose to participate in observational studies, while 
Athey & Imbens [35] modify the conventional classification and regression trees (CART) 
approach to estimate heterogeneous causal effects in such studies. CTA has also been proposed 
as an approach to identify potential instrumental variables (IV) that may provide an unbiased 
estimate of the causal effect of intervention on the outcome [10]. An IV is a variable that is 
correlated with the intervention, but not associated with unobserved confounders of the outcome 
[36]. Similarly, CTA can be used to identify causal mediation effects. A mediator is an 
intermediate variable which lies on the casual pathway between treatment and outcome [37]. A 
CTA model would be generated to predict the outcome, forcing the inclusion of the mediator 
after the treatment (to ensure correct temporal alignment), as well as including other covariates 
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to control for confounding. In such a model, the extent of mediation effects can be elucidated by 
assessing the ESS and P-values for each node along the pathway from treatment to outcome via 
the mediator. As indicated by these examples, the application of machine-learning techniques to 
improve causal inference in observational studies is open to much further exploration. And 
particular emphasis should be placed on determining the most appropriate algorithm for a given 
problem -- or a generalization to all algorithms, extension to outcomes with censored data [38], 
and the development of specific sensitivity analyses for these applications [39] to ensure that the 
resulting models remain robust to changes in assumptions and inputs. 
 In summary, when ODA is combined with matching techniques within a treatment effects 
framework, the results are consistent with conventional approaches. However, given that ODA 
provides additional dimensions and robustness to the analysis are available than what can 
currently be achieved using conventional approaches, it offers an appealing alternative. More 
broadly, health researchers should consider the many potential uses of machine learning 
algorithms to improve causal inference in observational studies. 
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Table 1: Baseline (12 months) characteristics of program participants and non-participants (from [10,21]). Continuous variables are 











Demographic characteristics        
Age 54.9 (6.71)  43.4  (11.99)  1.704  <0.001 
Female 211 (56.4%)  807 (49.6%)  0.138  0.017 
        
Utilization and Cost        
Primary care visits 11.3 (7.30)  4.6 (4.35)  0.914  <0.001 
Other outpatient visits 18.0 (16.65)  7.2 (10.61)  0.647  <0.001 
Laboratory tests 6.1 (5.27)  2.4 (3.31)  0.705  <0.001 
Radiology tests 3.2 (4.46)  1.3 (2.48)  0.424  <0.001 
Prescriptions filled 40.6 (29.96)  11.9 (17.14)  0.956  <0.001 
Hospitalizations 0.2 (0.52)  0.1 (0.29)  0.326  <0.001 
Emergency department visits 0.4 (1.03)  0.2 (0.50)  0.226  <0.001 
Home-health visits 0.1 (0.88)  0.0 (0.38)  0.083  0.012 
Total costs 8236 (9830)   3047 (5817)  0.528  <0.001 
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Table 2: Comparison of baseline characteristics of program participants and their 1:1 propensity score matched controls (from 









Demographic characteristics       
Age 54.6 (6.5)  54.0 (6.9)  0.082 0.316 
Female 152 (55.1%)  150 (54.3%)  0.015 0.864 
       
Utilization and Cost       
Primary care visits 9.5 (6.5)  9.7 (6.2)  0.022 0.803 
Other outpatient visits 15.2 (16.2)  15.6 (14.1)  0.029 0.751 
Laboratory tests 4.8 (5.8)  5.2 (4.5)  0.086 0.380 
Radiology tests 2.8 (4.4)  2.8 (4.1)  0.009 0.920 
Prescriptions filled 32.6 (27.8)  34.1 (25.3)  0.058 0.516 
Hospitalizations 0.2 (0.4)  0.2 (0.4)  0.026 0.768 
Emergency department visits 0.3 (0.8)  0.3 (0.9)  0.027 0.729 
Home-health visits 0.1 (0.9)  0.1 (1.0)  0.011 0.894 
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Table 3: Baseline (12 months) characteristics of program participants and non-participants (from [10,21]). Values represent cut-points 












Demographic characteristics        
Age > 49.5 (79.95)  ≤ 49.5 (63.70)  43.64%  <0.001 
Female = 1 (56.42)  = 0 (50.43)  6.85%  0.020 
        
Utilization and Cost        
Primary care visits > 7.5 (67.38)  ≤ 7.5 (82.68)  50.06%  <0.001 
Other outpatient visits > 6.5 (75.13)  ≤ 6.5 (68.86)  43.99%  <0.001 
Laboratory tests > 2.5 (78.07)  ≤ 2.5 (67.38)  45.46%  <0.001 
Radiology tests > 1.5 (64.44)  ≤ 1.5 (69.96)  34.40%  <0.001 
Prescriptions filled > 16.5 (80.75)  ≤ 16.5 (77.09)  57.84%  <0.001 
Hospitalizations > 0.5 (19.25)  ≤ 0.5 (94.16)  13.42%  <0.001 
Emergency department visits > 0.5 (22.99)  ≤ 0.5 (88.45)  11.45%  <0.001 
Home-health visits > 2.5 (1.60)  ≤ 2.5 (99.82)  1.42%  0.002 
Total costs > 2773 (85.03)   ≤ 2773 (71.74)  56.77%  <0.001 
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Table 4: Comparison of baseline characteristics of program participants and their 1:1 propensity score matched controls (from 











Demographic characteristics       
Age ≤ 52.5 (37.68)  > 52.5 (70.29)  7.97% 0.215 
Female = 0 (45.65)  = 1 (55.07)  0.72% 0.932 
       
Utilization and Cost       
Primary care visits > 2.5 (96.38)  ≤ 2.5 (9.06)  5.43% 0.590 
Other outpatient visits > 5.5 (74.64)  ≤ 5.5 (35.51)  10.14% 0.072 
Laboratory tests >  3.5 (59.06)  ≤ 3.5 (49.64)  8.70% 0.115 
Radiology tests > 0.5 (80.80)  ≤ 0.5 (24.28)  5.07% 0.519 
Prescriptions filled > 16.5 (76.09)  ≤ 16.5 (35.87)  11.96% 0.027 
Hospitalizations > 0.5 (14.86)  ≤0.5 (87.32)  2.17% 0.546 
Emergency department visits > 0.5 (21.38)  ≤ 0.5 (84.06)  5.43% 0.123 
Home-health visits > 2.5 (1.45)  ≤ 2.5 (98.91)  0.36% 0.847 
Total costs > 4629 (49.64)  ≤ 4629 (61.23)  10.87% 0.079 
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Table 5: Program year costs for participants and non-participants (unadjusted), and for matched pairs as estimated by ordinary least 
squares (OLS) regression. Values are reported as mean (standard error).  
  Participants Non-Participants Difference P-value 95% CI 
Naïve estimate (unadjusted)1 7,325 (513) 3,287 (246) 4,038 (569) < 0.0001 2,922, 5,154 
Matched pairs OLS regression2 5,709 (449) 7,210 (1,060) -1501 (1,151) 0.193 -3,762, 760 
1 374 participants, 1628 non-participants 
2 274 matched pairs 
 
Table 6: Program year costs for participants and non-participants (unadjusted), and for matched pairs as estimated by optimal 
discriminant analysis (ODA). Values are reported as cut-points on program year costs, and values in parentheses represent sensitivity 
(for participants) and specificity (for non-participants). Permuted P-values are derived using 25,000 Monte-Carlo experiments. 




Naïve estimate (unadjusted)1 < 2,773 (85.03%) ≥ 2,773 (71.74%) 56.77% < 0.0001 
Matched pairs ODA2 < 4,629 (49.64%) ≥ 4,629 (61.23%) 10.87% 0.076 
1 374 participants, 1628 non-participants  
2 274 matched pairs 
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